CLONIDINE HYDROCHLORIDE
CLONIDINE HYDROCHLORIDE
Approval overview CLONIDINE HYDROCHLORIDE is listed in Drugs@FDA under application 211433 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient CLONIDINE HYDROCHLORIDE Form and strength TABLET, EXTENDED RELEASE;ORAL - 0.1MG Sponsor SOMERSET THERAPS LLC Submission history Latest submission status date: 2020-05-21 00:00:00.
Structured Monograph
Clinical summary
Approval overview CLONIDINE HYDROCHLORIDE is listed in Drugs@FDA under application 211433 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient CLONIDINE HYDROCHLORIDE Form and strength TABLET, EXTENDED RELEASE;ORAL - 0.1MG Sponsor SOMERSET THERAPS LLC Submission history Latest submission status date: 2020-05-21 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.